What Researchers Did
Researchers conducted a retrospective study to investigate if adding stellate ganglion block (SGB) to hyperbaric oxygen therapy (HBO) and intratympanic steroids (ITS) improved outcomes for patients with refractory sudden sensorineural hearing loss (RSSNHL).
What They Found
Both treatment groups showed post-treatment hearing improvement (P < .05), but the group receiving SGB in addition to HBO and ITS achieved greater hearing gain, higher efficacy rates, and superior low-frequency recovery (P < .05). This triple therapy group also experienced significantly better tinnitus relief and psychological outcomes (P < .05). Earlier therapy initiation and lower baseline hearing thresholds were associated with greater hearing improvement.
What This Means for Canadian Patients
For Canadian patients with refractory sudden sensorineural hearing loss, this study suggests that combining hyperbaric oxygen therapy and intratympanic steroids with a stellate ganglion block could offer a more effective salvage treatment. This approach may lead to better hearing recovery, particularly in low-frequency ranges, and also help reduce tinnitus and improve psychological well-being. Early intervention appears to be key for better results.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a retrospective study, meaning it looked back at existing patient data, which can limit the control over variables and introduce potential biases.